Compare KZIA & RBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KZIA | RBOT |
|---|---|---|
| Founded | 1994 | 2014 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.6M | 17.0M |
| IPO Year | 1999 | N/A |
| Metric | KZIA | RBOT |
|---|---|---|
| Price | $13.05 | $3.05 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 1 |
| Target Price | ★ $16.00 | $7.00 |
| AVG Volume (30 Days) | ★ 1.9M | 145.0K |
| Earning Date | 12-26-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,199,108.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.86 | $2.44 |
| 52 Week High | $25.40 | $19.00 |
| Indicator | KZIA | RBOT |
|---|---|---|
| Relative Strength Index (RSI) | 67.12 | 39.32 |
| Support Level | $7.68 | $2.54 |
| Resistance Level | $11.13 | $3.66 |
| Average True Range (ATR) | 2.06 | 0.39 |
| MACD | 0.52 | 0.10 |
| Stochastic Oscillator | 69.83 | 38.28 |
Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.
Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port. The company has following segment: Research and development, Sales and marketing, General and administrative.